301122 Stock Overview
Engages in the research, development, production, and sale of injection needles, syringes and other related medical devices.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Caina Technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥18.69 |
| 52 Week High | CN¥44.20 |
| 52 Week Low | CN¥17.27 |
| Beta | 0.59 |
| 11 Month Change | 2.64% |
| 3 Month Change | -21.86% |
| 1 Year Change | -43.94% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -66.47% |
Recent News & Updates
Shareholder Returns
| 301122 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | 1.8% | 0.6% | -2.6% |
| 1Y | -43.9% | -15.4% | -20.6% |
Return vs Industry: 301122 underperformed the CN Medical Equipment industry which returned -15.4% over the past year.
Return vs Market: 301122 underperformed the CN Market which returned -20.6% over the past year.
Price Volatility
| 301122 volatility | |
|---|---|
| 301122 Average Weekly Movement | 5.3% |
| Medical Equipment Industry Average Movement | 5.1% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in CN Market | 9.0% |
| 10% least volatile stocks in CN Market | 3.8% |
Stable Share Price: 301122's share price has been volatile over the past 3 months.
Volatility Over Time: 301122's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 689 | Jun Lu | www.caina.ltd |
Caina Technology Co., Ltd. engages in the research, development, production, and sale of injection needles, syringes and other related medical devices. It offers disposable sterile safe self-destructing syringes, disposable insulin syringes, disposable sterile insulin pen needles, disposable sterile blood collection needles, and other sterile medical devices. Caina Technology Co., Ltd.
Caina Technology Co., Ltd. Fundamentals Summary
| 301122 fundamental statistics | |
|---|---|
| Market cap | CN¥2.28b |
| Earnings (TTM) | CN¥113.51m |
| Revenue (TTM) | CN¥368.44m |
20.1x
P/E Ratio6.2x
P/S RatioIs 301122 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 301122 income statement (TTM) | |
|---|---|
| Revenue | CN¥368.44m |
| Cost of Revenue | CN¥234.33m |
| Gross Profit | CN¥134.11m |
| Other Expenses | CN¥20.59m |
| Earnings | CN¥113.51m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Aug 28, 2024
| Earnings per share (EPS) | 0.93 |
| Gross Margin | 36.40% |
| Net Profit Margin | 30.81% |
| Debt/Equity Ratio | 0% |
How did 301122 perform over the long term?
See historical performance and comparison